在进行死因分析时，接受伊马替尼治疗的患者的总体生存率为88%。
The estimated overall survival rate for patients receiving Gleevec was 88% when considering deaths from all causes.
癌症在年轻女性中的发病呈蔓延趋势，并且患乳腺癌的年轻女性总体生存率低于老年女性患者。
Cancer in younger women tends to be more likely to recur or spread, and young women with breast cancer have a lower overall survival rate than older women with cancer.
结果：本组盆腔淋巴结阴性患者的五年总体生存率为82 0 %，中位生存时间10 0 0月。
Results: the overall 5-year survival of the patients was 82.0% and the median survival time was 100.0 months.
患者接受了三种不同治疗方案，平均生存期10个月，三年内总体生存率是27%。
With patients receiving the three different treatments, average survival was 10 months with a 27% overall survival rate at three years.
患者接受了三种不同治疗方案，平均生存期10个月，三年内总体生存率是27%。
With patients receiving the three different treatments, average survival was 10 months with a 27% overall survival rate at three years.
应用推荐